Armata Pharmaceuticals (ARMP) Gains from Sales and Divestitures (2021 - 2026)
Armata Pharmaceuticals' (ARMP) quarterly Gains from Sales and Divestitures came in at $17500.0 in Q1 2026, little changed year-on-year from $17500.0 in Q1 2025, and down 74.07% quarter-over-quarter from $67500.0 in Q4 2025.
Armata Pharmaceuticals (ARMP) Gains from Sales and Divestitures (2021 - 2026) Analysis & Trends
Armata Pharmaceuticals has disclosed Gains from Sales and Divestitures across 6 years of filings, most recently posting $17500.0 for Q1 2026.
- Gains from Sales and Divestitures for Q1 2026 came in at $17500.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $17500.0 (changed 0.0% YoY), and the FY2025 annual result was $67500.0, up 35.0% from the prior year.
- Gains from Sales and Divestitures came in at $17500.0 for Q1 2026 at Armata Pharmaceuticals, down from $67500.0 in the prior quarter.
- In the past five years, Gains from Sales and Divestitures ranged from a high of $102325.0 in Q4 2023 to a low of $17500.0 in Q1 2025.
- The 5-year median for Gains from Sales and Divestitures is $50000.0 (2024), against an average of $43967.4.
- Across the five-year window, Gains from Sales and Divestitures slumped 85.7% in 2022 and jumped 326.66% in 2023, its largest moves.
- Armata Pharmaceuticals' Gains from Sales and Divestitures stood at $23983.0 in 2022, then surged by 326.66% to $102325.0 in 2023, then plunged by 51.14% to $50000.0 in 2024, then surged by 35.0% to $67500.0 in 2025, then tumbled by 74.07% to $17500.0 in 2026.
- The last three Gains from Sales and Divestitures figures came in at $17500.0 (Q1 2026), $67500.0 (Q4 2025), and $67500.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Armata Pharmaceuticals | 275.44 Mn | 270.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17,500.00 |
| Mar 31, 2026 | 17,500.00 |
| Dec 31, 2025 | 67,500.00 |
| Dec 31, 2025 | 67,500.00 |
| Sep 30, 2025 | 67,500.00 |
| Sep 30, 2025 | 67,500.00 |
| Jun 30, 2025 | 17,500.00 |
| Jun 30, 2025 | 17,500.00 |
| Mar 31, 2025 | 17,500.00 |
| Mar 31, 2025 | 17,500.00 |
| Dec 31, 2024 | 50,000.00 |
| Dec 31, 2024 | 50,000.00 |
| Sep 30, 2024 | 50,000.00 |
| Sep 30, 2024 | 50,000.00 |
| Dec 31, 2023 | 102,325.00 |
| Dec 31, 2023 | 102,325.00 |
| Sep 30, 2023 | 54,901.00 |
| Sep 30, 2023 | 54,901.00 |
| Jun 30, 2023 | 54,901.00 |
| Jun 30, 2023 | 54,901.00 |